medigraphic.com
ISSN 1561-2902 (Electronic)

2022, Number 3

<< Back Next >>

Revista Cubana de Educación Médica Superior 2022; 36 (3)

A literature review about post-COVID-19 syndrome

Perilla PEJ, Perilla PFE, Fuentes CSR

Language: Spanish
References: 51
Page: 1-15
PDF size: 301.18 Kb.


ABSTRACT

Introduction: COVID-19 is a viral disease that has caused great affectation in the health of the global population. Several studies have shown that two to three months after coronavirus infection patients continue to report symptoms, fatigue, dyspnea and headache being the most frequent.
Objective: To present relevant scientific information on post-COVID-19 syndrome.
Development: A literature review was conducted between November 2020 and February 2021, consisting of the phases of planning, design and management, analysis, elaboration and formalization. The strategic search was carried out using ScienceDirect, PubMed/Medline, NusrginsOvid, SciELO and Google Scholar, through the combination of the Boolean operators OR, AND and NOT. Full texts were considered, in Spanish, English and Portuguese, from 2019 to 2021. After the selection and an in-depth review, 38 articles were obtained that met the set objective, which were processed with the PRISMA methodology.
Conclusions: There is a post-COVID-19 syndrome, directly related to a multisystem inflammatory process, which shows symptoms in patients three months after the end of the infectious process. Among these, fatigue, dyspnea and headache are the most frequent, in addition to cardiac, psychological and neurobiological consequences.


REFERENCES

  1. Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, et al. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak-an update on the status. Military Medical Research. 2020;7(1):11-3. DOI: https://doi.org/10.1186/s40779-020-00240-01.

  2. Dae-Gyun A, Hye-Jin S, Mi-Hwa K, Sunhee L, Hae-Soo K, Jinjong M, et al. Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19). J. Microbiol. Biotechnol. 2020;30(3):313-24. DOI: http://doi.org/10.4014/jmb.2003.030112.

  3. Liu J, Zheng X, Tong Q, Li W, Wang B, Sutter K, et al. Overlapping and discrete aspects of the pathology and pathogenesis of the emerging human pathogenic coronaviruses SARS-CoV, MERS-CoV, and 2019-nCoV. J Med Virol. 2020 [access 08/01/2021];92(5):491-4. Available from: https://umsu.ac.ir/uploads/90.pdf3.

  4. Riou M, Marcot C, Canuet M, Renaud-Picard B, Chatron E, Porzio M, et al. Clinical characteristics of and outcomes for patients with COVID-19 and comorbid lung diseases primarily hospitalized in a conventional pulmonology unit: A retrospective study. Respiratory Medicine and Research. 2021;79:100801. DOI: https://doi.org/10.1016/j.resmer.2020.1008014.

  5. Ruiz-Aquino MM, Diaz-Lazo AV, Ortiz-Aguí ML. Creencias, conocimientos y actitudes frente a la COVID-19 de pobladores adultos peruanos en cuarentena social. Rev Cubana Enferm. 2020 [acceso 10/01/2021];36(0):1-15. Disponible en: http://www.revenfermeria.sld.cu/index.php/enf/article/view/42515.

  6. Organización Panamericana de la Salud. La OMS caracteriza a COVID-19 como una pandemia. Organización Panamericana de la Salud/Organización Mundial de Salud 2020 [acceso 10/01/2021]. Disponible en: https://www.paho.org/es/noticias/11-3-2020-oms-caracteriza-covid-19-como-pandemia6.

  7. da Silva DP, García Suárez JA. Evidencias de la acción de agentes biocidas en la prevención y control de infecciones por coronavirus humanos. Rev Cubana Enferm. 2020 [acceso 10/01/2021];36(0). Disponible en: http://www.revenfermeria.sld.cu/index.php/enf/article/view/38867.

  8. Santos Ferreira RB. Víctimas preferidas de COVID-19 en diferentes países según raza/color de la piel. Rev Cubana Enferm. 2020 [acceso 10/01/2021];36(0). Disponible en: http://www.revenfermeria.sld.cu/index.php/enf/article/view/39418.

  9. Deng SQ, Peng HJ. Characteristics of and public health responses to the coronavirus disease 2019 outbreak in China. J Clin Med. 2020;9(2):575. DOI: http://doi.org/10.3390/jcm90205759.

  10. Zhou P, Yang XL, Wang XG, Hu B, Zhang L, Zhang W, et al. A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature. 2020;579(7798):270-3. DOI: http://doi.org/10.1038/s41586-020-2012-710.

  11. Chan JFW, Yuan S, Kok KH, To KK, Chu H, Yang J, et al. A familial cluster of pneumonia associated with the 2019 novel coronavirus indicating person-toperson transmission: a study of a family cluster. The Lancet. 2020;395(10223):514-23. DOI: https://doi.org/10.1016/S0140-6736(20)30154-911.

  12. Chilán Pincay A, Chong Lo L, Ling Salazar V, Muñoz Barberán M. Consecuencias a largo plazo en pacientes con infección por SARS-CoV-2: Síndrome Post Covid-19. SERIE. 2021 [acceso 3/02/2021];14(2):51-3. Disponible en: https://publicaciones.uci.cu/index.php/serie/article/view/73912.

  13. Bustos B.R. Pediatric multisystem inflammatory syndrome associated with SARS-CoV-2. Rev. chil. pediatr. 2020;91(4):646-647. DOI: http://dx.doi.org/10.32641/rchped.v91i4.261613.

  14. Orozco-Hernández JP, Marin-Medina DS & Sánchez-Duque. Manifestaciones neurológicas de la infección por SARS-CoV-2 [Manifestaciones neurológicas de la infección por SARS-CoV-2]. Semergen. 2020;46(Suppl 1):106-8. DOI: https://doi.org/10.1016/j.semerg.2020.05.00414.

  15. Goërtz YM, Van Herck M, Delbressine JM, Vaes AW, Meys R, Machado F, et al. Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ open research. 2020;6(4). DOI: http://doi.org/10.1183/23120541.00542-202015.

  16. Carfì A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. Jama. 2020;324(6):603-5. DOI: http://doi.org/10.1001/jama.2020.1260316.

  17. Acosta R, Rodríguez I, Solís M, Torres R, García C. Rehabilitación post COVID-19: un desafío vigente. Rev. méd. Chile. 2020;148(10):1531-2. DOI: http://dx.doi.org/10.4067/S0034-9887202000100153117.

  18. Ayala D, Espinoza TM. Utilidad de la simulación clínica para lograr competencias en estudiantes de enfermería en tiempos de COVID-19. Rev Cubana Enferm. 2020 [acceso 15/01/2021];36(0). Disponible en: http://www.revenfermeria.sld.cu/index.php/enf/article/view/394618.

  19. Gómez Vargas M, Vargas MG, Higuita CG, Muñoz DAJ. El estado del arte: una metodología de investigación. Rev Colomb Cienc Soc. 2015;6(2):423-42. DOI: https://doi.org/10.21501/22161201.146919.

  20. Londoño OL, Maldonado LF, Calderón LC. Guías para construir estados del arte 1 Ed. Bogotá: International Corporation of Networks of Knowiedge; 2016. Disponible en: https://iconk.org/docs/guiaea.pdf [ Links ]

  21. Lamprecht B. Gibt es ein Post-COVID-Syndrom?. Der Pneumologe. 2020;17:398-405. DOI: https://doi.org/10.1007/s10405-020-00347-021.

  22. Tenforde MW, Kim SS, Lindsell CJ, Billig Rose E, Shapiro NI, Files D, et al. Duration and Risk Factors for Delayed Return to Usual Health Among Outpatients with COVID-19 in a Multistate Health Care Systems Network-United States, Morbidity and mortality weekly report. 2020;69(30):993-8. DOI: https://doi.org/10.15585/mmwr.mm6930e122.

  23. An Dam LS, Kraaij T, Kamerling SWA, Bakker JA, Scherer UH, Rabelink TJ, et al. Intrinsically Distinct Role of Neutrophil Extracellular Trap Formation in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis Compared to Systemic Lupus Erythematosus. Arthritis Rheumatol. 2019;71(12):2047-58. DOI: https://doi.org/10.1002/art.4104723.

  24. Sawadogo SA, Dighero-Kemp B, Ouédraogo DD, Hensley L, Sakandé J. How NETosis could drive "Post-COVID-19 syndrome" among survivors. Immunology letters. 2020;228:35-7. DOI: https://dx.doi.org/10.1016%2Fj.imlet.2020.09.00524.

  25. 25. Desilles JP, Gregoire C, Le Cossec C, Lambert J, Mophawe O, Losser MR, et al. Efficacy and safety of aerosolized intra-tracheal dornase alfa administration in patients with SARS-CoV-2-induced acute respiratory distress syndrome (ARDS): a structured summary of a study protocol for a randomised controlled trial. Trials. 2020;21(1):1-3. DOI: https://doi.org/10.1186/s13063-020-04488-826.

  26. Carvelli J, Demaria O, Vély F, Batista L, Benmansour NC, Fares J, et al. E. Association of COVID-19 inflammation with activation of the C5a-C5aR1 axis. Nature. 2020;588:146-50. DOI: https://doi.org/10.1038/s41586-020-2600-627.

  27. Lu R, Zhao X, Li J, Niu P, Yang B, Song H, et al. Genomic characterization and epidemiology of 2019 novel coronavirus: implications for virus origins and receptor binding. Lancet. 2020;395(10224):565-74. DOI: https://doi.org/10.1016/S0140-6736(20)30251-828.

  28. Perrin R, Riste L, Hann M, Walther A, Mukherjee A, Heald A. Into the looking glass: Post-viral syndrome post COVID-19. Med Hypotheses. 2020;144:110055. DOI: https://doi.org/10.1016/j.mehy.2020.11005529.

  29. Garg P, Arora U, Kumar A, Wig N. The "post-COVID" syndrome: How deep is the damage? Journal of medical virology. 2020;93(2):673-4. DOI: https://doi.org/10.1002/jmv.2646530.

  30. Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395(10229):1054-62. DOI: https://doi.org/10.1016/S0140-6736(20)30566-331.

  31. Liu J, de Luca R, Mello H, Barcellos I. Post-COVID-19 Syndrome? New daily persistent headache in the aftermath of COVID-19. Arq. Neuro-Psiquiatr. 2020;78(11):753-4. DOI: https://doi.org/10.1590/0004-282x2020018732.

  32. Sampaio PA, Voss L. Persistent headache and persistent anosmia associated with COVID-19. Headache: The Journal of Head and Face Pain. 2020;60(8):1797-9. DOI: https://dx.doi.org/10.1111%2Fhead.1394133.

  33. Yamani N, Olesen J. New daily persistent headache: a systematic review on an enigmatic disorder. The journal of headache and pain. 2019;20(1):1-9. DOI: https://doi.org/10.1186/s10194-019-1022-z34.

  34. Chan M, Han SC, Kelly S, Tamimi M, Giglio B, Lewis A. A case series of Guillain-Barré Syndrome following Covid-19 infection in New York. Neurology: Clinical Practice. 2020;11(4):576-8. DOI: https://doi.org/10.1212/CPJ.000000000000088035.

  35. Carroll E, Neumann H, Aguero-Rosenfeld ME, Lighter J, Czeisler BM, Melmed K, et al. Post-COVID-19 inflammatory syndrome manifesting as refractory status epilepticus. Epilepsia. 2020;61(10):135-9. DOI: https://doi.org/10.1111/epi.1668336.

  36. Novi G, Rossi T, Pedemonte E, Saitta L, Rolla C, Roccatagliata L, et al. Acute disseminated encephalomyelitis after SARS-CoV-2 infection. Neurol Neuroimmunol Neuroinflamm. 2020;7(5). DOI: https://doi.org/10.1212/nxi.000000000000079737.

  37. Kempuraj D, Selvakumar GP, Ahmed ME, Raikwar SP, Thangavel R, Khan A, et al. COVID-19, mast cells, cytokine storm, psychological stress, and neuroinflammation. The Neuroscientist. 2020;26(5-6):402-14. DOI: https://doi.org/10.1177/107385842094147639.

  38. Afrin LB, Weinstock LB, Molderings GJ. Covid-19 hyperinflammation and post-Covid-19 illness may be rooted in mast cell activation syndrome. International journal of infectious diseases. 2020;100:327-32. DOI: https://dx.doi.org/10.1016%2Fj.ijid.2020.09.01640.

  39. Spagnolo P, Balestro E, Aliberti S, Cocconcelli E, Biondini D, Della Casa G, et al. Pulmonary fibrosis secondary to COVID-19: a call to arms?. The Lancet Respiratory Medicine. 2020;8(8):750-2. DOI: https://doi.org/10.1016/S2213-2600(20)30222-841.

  40. Bono JOE., Barcudi R. Daño residual cardiovascular post-COVID. Rev Fed Arg Cardiol. 2020 [acceso 15/02/2021];49(4):129-32. Disponible en: https://www.fac.org.ar/revista/volumen/49/numero/4/38/38.pdf42.

  41. Alfonso O, Aylen A, Marcos Y, Rodríguez L, Martínez A, Kenia K, et al. Relación entre electrocardiograma y resonancia magnética cardíaca en la topografía del infarto de miocardio previo. CorSalud. 2021 [acceso 15/02/2021];14(1). Disponible en: http://www.revcorsalud.sld.cu/index.php/cors/article/view/68643.

  42. Huang L, Zhao P, Tang D, Zhu T, Han R, Zhan C, et al. Cardiac involvement in patients recovered from COVID-2019 identified using magnetic resonance imaging. Cardiovascular Imaging. 2020;13(11):2330-9. DOI: https://doi.org/10.1016/j.jcmg.2020.05.00444.

  43. Puntmann VO, Carerj ML, Wieters I, Fahim M, Arendt C, Hoffmann J, et al. Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19). JAMA cardiology. 2020;5(11):1265-73. DOI: https://dx.doi.org/10.1001%2Fjamacardio.2020.355745.

  44. Sher L. Post-COVID syndrome and suicide risk. QJM. 2021;114(2):95-8. DOI: https://doi.org/10.1093/qjmed/hcab00746.

  45. Jiang DH, McCoy RG. Planning for the Post-COVID Syndrome: How Payers Can Mitigate Long-Term Complications of the Pandemic. J GEN INTERN MED. 2020;35:3036-9. DOI: https://doi.org/10.1007/s11606-020-06042-347.

  46. 2. Quintero J, Mora F, Rodriguez-Quiroga A, Alvarez de Mon MA, Lopez-Ibor MI. Post-COVID Mental Health. Actas Españolas de Psiquiatría. 2020 [acceso 15/02/2021];48(2):96-8. Disponible en: http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=mesx&NEWS=N&AN=3246391748. 2.

  47. Junhua M, Qi Z, Xue G, Lijuan L, Zhongwen Z, Jing W. Analysis of psychological and sleep state of medical stuff with novel coronavirus pneumonia. Herald Med. 2020;39(3):345-9. DOI: https://doi.org/10.1016/j.jns.2020.11717949.

  48. Wijeratne T, Crewther S. Post-COVID 19 Neurological Syndrome (PCNS); a novel syndrome with challenges for the global neurology community. Journal of the neurological sciences. 2020;419:117-79. DOI: https://doi.org/10.1016/j.jns.2020.11717950.

  49. Schmulson M, Ghoshal Uday C, Barbara G. Managing the Inevitable Surge of Post-COVID-19 Functional Gastrointestinal Disorders. The American Journal of Gastroenterology. 2021;116(1):4-7. DOI: http://doi.org/10.14309/ajg.000000000000106251.

  50. Deshmukh V, Motwani R, Kumar A, Kumari C, Raza K. Histopathological observations in COVID-19: a systematic review. Journal of Clinical Pathology. 2021;74(2):76-83. DOI: http://dx.doi.org/10.1136/jclinpath-2020-20699552.

  51. Zuo T, Zhang F, Lui GC, Yeoh YK, Li AY, Zhan H, et al. Alterations in gut microbiota of patients with COVID-19 during time of hospitalization. Gastroenterology. 2020;159(3):944-55. DOI: https://doi.org/10.1053/j.gastro.2020.05.04853.




2020     |     www.medigraphic.com